Browser does not support script.
Translational Cancer Medicine enables you to gain detailed knowledge and understanding of research methods applied to rational drug design, clinical study design, molecular and cell biology, tumour immunology, genetics and cancer imaging. You'll gain practical experience through two six-month laboratory rotations.
Application status Open
Duration One year FT, September to September
Study mode Full-time
Credit value UK 180/ECTS 90
Course intake 10-14 FT
Course leaders Prof Tony Ng, Programme Director
Prof Tony Ng, Programme Director
Course contact for further information Postgraduate Admissions Team, Admissions Office tel: +44 (0) 20 7848 7000 fax: +44 (0) 20 7848 7200
Postgraduate Admissions Team, Admissions Office tel: +44 (0) 20 7848 7000 fax: +44 (0) 20 7848 7200
Course contact form Postgraduate admissions enquiry form
Awarding institution King's College London
Faculty Faculty of Life Sciences & Medicine
Visit our admissions webpages to view our English language entry requirements.
First class or high 2:1 BSc (honours) degree or overseas equivalent in biomolecular or physical sciences. MBBS students can be admitted at any time following the third year of their programme. Post-year three: entry is based on year three performance plus evidence of knowledge of the basic elements of translational research topics. Advanced years (four to five): students must complete their current year of study. External students need to obtain permission from their own medical school and provide evidence of their exam performance in the pre-clinical examinations.
Applications are made on-line. To apply, please select the 'Apply' button at the top right of this page. Applications are subject to a £50 non-refundable application fee.
Please detail your research experience and any previous laboratory experience. Include your reason for applying and career aims. Please specify two areas of interest from the list of projects in the description. MBBS students should provide a statement demonstrating knowledge of basic elements of translational research topics such as epidemiology, clinical biostatistics and clinical pharmacology (relating to drug discovery).
The deadline for applications for September 2017 entry is 31st March 2017. After this date, programmes will remain open if places are available, and programmes will be closed as soon as they are full, so we encourage you to submit your application as soon as possible. For programmes with spaces remaining, no further applications will be accepted from non-EU (Overseas) nationals after 30th July 2017 or from UK/ EU nationals after 3rd September 2017.
The Translational Cancer Medicine MRes study pathway offers unique opportunities for you to join experienced research teams and work on particular projects from the outset. This course will allow you to develop an in-depth understanding of research methods, and of how theoretical academic studies and skills relate to research projects.
Initially, you will explore Fundamentals of Translational Cancer Medicine, providing you with advanced knowledge and skills to conceptualise, design, conduct and critically appraise specialist research. You will then complete two six-month research modules, which are worth 75 credits each.
Research projects include
Cancer Biostatistics & Epidemiology
Dr Mieke Van Hemelrijck
Serum biomarkers and risk of cancer in the Swedish AMORIS dataset - data on 800,000 men and women
Cancer functional genomics, computational biology
Dr Francesca Ciccarelli
Validation of actionable genes in colorectal cancer
Cancer Cell Biology
Prof Anne Ridley
Targeting Rho signalling networks in cancer invasion and metastasis
Dr James Arnold
Tumour associated macrophages in cancer progression
Dr Jeremy Carlton
Regulation of cell division and receptor degradation by the ESCRT-machinery
Dr Gilbert Fruhwirth
Multi-modal in vivo imaging for monitoring cancer treatment
Cancer Cell Biology & Imaging
Prof Tony Ng
cMet/ErbB and exosomes in non-small cell lung cancer
Prof Vicky Goh & Prof Gary Cook
Optimising multimodality treatment response assessment with imaging
Prof Fiona Watt & Dr Ines Sequeira
Mouse knockout screen for genes that control skin fibroblast lineages
Prof Mahvash Tavassoli
Predictive Biomarkers of Treatment Resistance in Head and Neck Squamous Cell Carcinoma
Prof Sarah Pinder
Molecular pathology of breast cancer precursors
Prof Farzin Farzaneh & Dr Kiki Ioannou
High throughput analysis of modulators of cellular immunity against cancer associated antigens
Dr Andrea Pepper & Dr Eve Coulter
Project to be confirmed
Dr Alan Ramsay
Investigating the tumour microenvironment (TME) and immune suppression in lymphoma
Prof Francesco Dazzi
Tumour associated stroma and therapeutic targets
Prof Ghulam Mufti
Truncal vs branch mutations in MDS/AML
Immune response in aplastic anaemia
Prof Joy Burchell
Changes in post-translational modifications (O-linked glycosylation) of breast cancer: The effect on tumour behaviour and immune recognition
Investigations of the impact of EGFR/HER3 treatments on the cancer: immune stromal microenvironment interface
Dr Debashis Sarker & Dr James Spicer
Factors affecting patient recruitment and experience in Phase 1 trials
Dr John Maher
Genetic targeting of T-cells against cancer
Dr Elinor Sawyer
Identification of genes that predispose to lobular breast cancer
Dr Anita Grigoriadis
Molecular characterisation of lymph nodes
Stem Cells and Bone Cancer
Prof Agamemnon Grigoriadis
Targeting FGFR signalling in bone tumour growth and metastasis
We use lectures, seminars and group meetings to deliver most of the modules on the programme. You will also be expected to undertake a significant amount of independent study.
On average teaching consists of:
Throughout the year, you will also attend literature reviews and journal clubs that the labs/departments organise, as well as any other internal or external seminars deemed relevant to your projects/assignments.
The primary method of assessment for this course is a combination of written essays, a thesis (research report), a presentation/Q&A session regarding the research report and a draft of a scientific paper.
We regularly review our modules to make sure our programmes are as up-to-date, innovative and relevant as possible. The modules we offer may therefore change. We suggest that you check the course finder for updates: http://www.kcl.ac.uk/study/postgraduate/index.aspx
Future PhD studies. Clinical and non-clinical academic careers in cancer medicine.
This course allowed me to be sure that I do want to do a PhD, in addition to exposing me to very varied areas of research in an engaging manner. I appreciated the level to which I managed my own time and workload and really enjoyed the process as a whole. In short I would highly recommend this course to anyone considering commencing a career in research.
In the heart of London
Discover the advantages of studying at one of the top 25 universities in the world and take a look at our central London campuses.
£10,950 p.a. (2017/18)*
£22,800 p.a. (2017/18)
*These tuition fees may be subject to additional increases in subsequent years of study, in line with King’s terms and conditions.
Please note: Current regulations allow some students to pay UK tuition fees on the basis of their EU citizenship or residency. Until these eligibility criteria are changed, the EU tuition fee will remain the same as the UK tuition fee.
When you receive an offer for this course you will be required to pay a non-refundable deposit to secure your place. The deposit will be credited towards your total fee payment.
The UK/EU deposit is £500.
The INTERNATIONAL deposit is £2,000.
Please visit our web pages on fees and funding for more information.
Full list of student events
Learn more about postgraduate degree programmes at King's. Download or view our guide in PDF format.
Start your academic journey at King's College London.